Your browser doesn't support javascript.
loading
A Quinoline-Based DNA Methyltransferase Inhibitor as a Possible Adjuvant in Osteosarcoma Therapy.
Manara, Maria Cristina; Valente, Sergio; Cristalli, Camilla; Nicoletti, Giordano; Landuzzi, Lorena; Zwergel, Clemens; Mazzone, Roberta; Stazi, Giulia; Arimondo, Paola B; Pasello, Michela; Guerzoni, Clara; Picci, Piero; Nanni, Patrizia; Lollini, Pier-Luigi; Mai, Antonello; Scotlandi, Katia.
Afiliação
  • Manara MC; Laboratory of Experimental Oncology, IRCCS - Istituto Ortopedico Rizzoli, Bologna, Italy.
  • Valente S; Department of Chemistry and Technologies of Drugs, Sapienza University of Rome, Rome, Italy.
  • Cristalli C; Laboratory of Experimental Oncology, IRCCS - Istituto Ortopedico Rizzoli, Bologna, Italy.
  • Nicoletti G; Laboratory of Experimental Oncology, IRCCS - Istituto Ortopedico Rizzoli, Bologna, Italy.
  • Landuzzi L; Laboratory of Experimental Oncology, IRCCS - Istituto Ortopedico Rizzoli, Bologna, Italy.
  • Zwergel C; Department of Chemistry and Technologies of Drugs, Sapienza University of Rome, Rome, Italy.
  • Mazzone R; Department of Chemistry and Technologies of Drugs, Sapienza University of Rome, Rome, Italy.
  • Stazi G; Center for Life NanoScience@Sapienza, Italian Institute of Technology, Rome, Italy.
  • Arimondo PB; Department of Chemistry and Technologies of Drugs, Sapienza University of Rome, Rome, Italy.
  • Pasello M; ETaC, Epigenetic Targeting of Cancer, CRDPF, CNRS-Pierre Fabre USR3388, Toulouse, France.
  • Guerzoni C; Laboratory of Experimental Oncology, IRCCS - Istituto Ortopedico Rizzoli, Bologna, Italy.
  • Picci P; Laboratory of Experimental Oncology, IRCCS - Istituto Ortopedico Rizzoli, Bologna, Italy.
  • Nanni P; Laboratory of Experimental Oncology, IRCCS - Istituto Ortopedico Rizzoli, Bologna, Italy.
  • Lollini PL; DIMES, Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, Italy.
  • Mai A; DIMES, Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, Bologna, Italy.
  • Scotlandi K; Department of Chemistry and Technologies of Drugs, Sapienza University of Rome, Rome, Italy. katia.scotlandi@ior.it antonello.mai@uniroma1.it.
Mol Cancer Ther ; 17(9): 1881-1892, 2018 09.
Article em En | MEDLINE | ID: mdl-29959201
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Benzamidas / Neoplasias Ósseas / Protocolos de Quimioterapia Combinada Antineoplásica / Osteossarcoma / Ensaios Antitumorais Modelo de Xenoenxerto / Inibidores Enzimáticos / DNA (Citosina-5-)-Metiltransferase 1 / Aminoquinolinas Tipo de estudo: Prognostic_studies Limite: Animals / Humans / Male Idioma: En Revista: Mol Cancer Ther Assunto da revista: ANTINEOPLASICOS Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Itália País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Benzamidas / Neoplasias Ósseas / Protocolos de Quimioterapia Combinada Antineoplásica / Osteossarcoma / Ensaios Antitumorais Modelo de Xenoenxerto / Inibidores Enzimáticos / DNA (Citosina-5-)-Metiltransferase 1 / Aminoquinolinas Tipo de estudo: Prognostic_studies Limite: Animals / Humans / Male Idioma: En Revista: Mol Cancer Ther Assunto da revista: ANTINEOPLASICOS Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Itália País de publicação: Estados Unidos